IGF1 and metabolic syndrome: Elevated levels of triglycerides, insulin, glucose, and IGF-1 have all been suggested as contributing to the association of the metabolic syndrome with increased risk of colorectal cancer (McKeown-Eyssen, 1994; Giovannucci, 1995).